期刊文献+

精神分裂症患儿利司培酮治疗前后血清瘦素和白细胞介素-1β变化的意义 被引量:3

Changes and Significances of Serum Leptin and Interleukin-1β before and after Treatment with Risperidone in Children with Schizophrenics
下载PDF
导出
摘要 目的探讨精神分裂症患儿利司培酮治疗前后血清瘦素和白细胞介素-1β(IL-1β)水平的变化及意义。方法观察组31例精神分裂症患儿,利司培酮治疗前和治疗8周后分别测量身高、体质量以计算体质量指数(BMI),用放射免疫法检测其空腹血清瘦素和IL-1β。选取31例健康儿童作为对照组。结果观察组治疗后BMI、血清瘦素水平均明显上升,与治疗前相比差异均有显著性(P均<0.05);观察组血清IL-1β水平在治疗前与对照组相比明显增高,治疗后明显下降,与治疗前相比差异有显著性(P<0.05)。结论首发精神分裂症患儿血清IL-1β水平明显升高,利司培酮治疗后易出现药源性肥胖,低IL-1β水平可能是瘦素抵抗的原因之一。 Objective To explore the changes and significances of serum leptin and interleukin - 1β( IL- 1β)before and after treatment with risperidone in children with schizophrenics. Methods Thirty - one cases with first - episode children with schizophrenia were chosen in patient group. Their body weight and height were measured before and 8 weeks after treatment with risperidone to calculate the body mass index(BMI), and their fasting srum lcptin and IL - 1β were assayed radio immunity method. Thirty - one healthy controls were measured at the same time. Results BMI and the level of serum leptin in patients of post - treatment increased significantly compared with those of pre- treatment (all P 〈 0.05 ). The level of serum IL - 1β in patients of pre treatment was significantly higher compared with that of controls, the level of serum IL - 1β after treatment decreased significantly( P 〈 0.05 ). Conclusions The serum IL - 1β level is higher in first - episode children with schizophrenia. Obesity is easy to be seen in the patients treated with risperidone. It may be one of reasons to leptin resistence to decrease serum IL-1β levels.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2006年第8期463-464,共2页 Journal of Applied Clinical Pediatrics
基金 "十五"国家科技攻关计划项目资助(2004BA720A22)
关键词 精神分裂症 瘦素 白细胞介素1 利司培酮 schizophrenia leptin interleukin - 1 risperidone
  • 相关文献

参考文献13

二级参考文献58

  • 1郭珍,李春波,吴文源,李华芳,王克勋.利培酮及氯氮平对治疗精神分裂症患者血清Leptin浓度影响的初步研究[J].上海精神医学,2002,14(1):23-25. 被引量:5
  • 2李为苏,黎介寿.肝硬化患者营养不良与围手术期营养支持[J].实用临床医药杂志,2004,8(5):26-28. 被引量:17
  • 3魏源.瘦素与运动[J].沈阳体育学院学报,2004,23(6):750-752. 被引量:1
  • 4Atmaca M, Kuloglu M, Tezcan E, et al. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics [J]. J Clin Psychiatry, 2003 ;64(5):598-604.
  • 5Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: A comprehensive research synthesis [J]. Am J Psychiatry, 1999; 156 (11): 1686-1696.
  • 6Kelly DL, Conley RR, Love RC, et al. Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months [J]. J Child Adolesc Psychopharmacol, 1998; 8 (3):151-159.
  • 7Ratzoni G, Gothelf D, Brand-Gothelf A, et al. Weight gain associated with olanzapine and risperidone in adolescent patients: A comparative prospective study [J]. J Am Acad Child Adolesc Psychiatry,2002 ;41 (3):337-343.
  • 8Simpson MM, Goetz RR, Devlin MJ, et al. Weight gain and antipsychotic medication: Differences between antipsychotic-free and treatment periods [J]. J Clin Psychiatry, 2001 ;62(9):694-700.
  • 9Kraus T, Haack M, Schuld A, et al. Body weight and leptin plasma levels during treatment with antipsychotic drugs [J]. Am J Psychiatry, 1999;156(2):312-314.
  • 10Hagg S, Soderberg S, Ahren B, et al. Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics [J]. J Clin Psychiatry, 2001 ;62(11):843-848.

共引文献130

同被引文献36

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部